Company: IOBT
Filing Date: 2025-07-24
Form Type: S-3
Source: 0001193125-25-164495
Chunk: 20

Company: IO Biotech, Inc.
Filing Date: 2025-07-24
Form: S-3
Chunk 20
---

Securities Act. Any discounts, commissions, concessions or profit they earn on any resale of the shares of our common stock may be underwriting discounts and commissions under the Securities Act. Each selling stockholder has informed us that it does
not have any written or oral agreement or understanding, directly or indirectly, with any person to distribute the securities.

The selling stockholders
are subject to the prospectus delivery requirements of the Securities Act.

To the extent required pursuant to Rule 424(b) under the Securities Act, the
shares of our common stock to be sold, the name of the selling stockholders, the purchase price and public offering price, the names of any agents, dealer or underwriter, and any applicable commissions or discounts with respect to a particular offer
will be set forth in an accompanying prospectus supplement or, if appropriate, a post-effective amendment to the registration statement that includes this prospectus.

We have agreed to keep this prospectus effective until the earliest to occur of the following events after the date in which the Tranche A Warrants, Tranche B
Warrants and the Tranche C Warrants have been issued pursuant to the Warrant Issuance Agreement or such earlier date on which the Company has no outstanding obligation to issue Warrants under the Warrant Issuance Agreement: (i) the date on
which the selling stockholders shall have resold all the Shares covered hereby; and iii) the date on which the Shares may be resold or transferred by the selling stockholders without registration and without regard to any volume or manner-of-sale limitations by reason of Rule 144, without the requirement for the Company to be in compliance with the current public information requirement under Rule 144
under the Securities Act or any other rule of similar effect, and new

14

certificates for such securities not bearing a legend restricting further transfer have been issued to the selling stockholders. In order to comply with the securities laws of some states, if
applicable, the shares of our common stock may be sold in these jurisdictions only through registered or licensed brokers or dealers. In addition, in some states the shares of our common stock may not be sold unless the shares been registered or
qualified for sale or an exemption from registration or qualification requirements is available and is complied with.

The selling stockholders and any
other person participating in a sale of shares of our common stock registered under this prospectus will be subject to applicable provisions of the Exchange Act, and the rules and regulations thereunder, including, without limitation,